Picture of Noile-Immune Biotech logo

4893 — Noile-Immune Biotech News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareMicro CapSucker Stock

Table: Noile-Immune Biotech -2024 parent results

Feb 14 (Reuters)- 
          Noile-Immune Biotech Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2024    Dec 31, 2023   Dec 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           7 mln          316 mln                               
               (-97.6 pct)     (-49.3 pct)                             
  Operating     loss 1.07     loss 775 mln                             
  Recurring   loss 962 mln      loss 1.13                              
  Net         loss 964 mln      loss 1.13                              
  EPS        loss 22.28 yen  loss 27.25 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T

Recent news on Noile-Immune Biotech

See all news